Literature DB >> 16463898

Microdialysis in traumatic brain injury--methodology and pathophysiology.

P J Hutchinson1.   

Abstract

The application of clinical microdialysis to monitor changes in cerebral extracellular chemistry is now well established in several neurosurgical units worldwide. In neuro-intensive care the technique has been predominantly applied to patients with traumatic brain injury and subarachnoid haemorrhage. There is no doubt that microdialysis has increased and continues to increase our understanding of the pathophysiology of these conditions. Current studies are addressing the potential role of microdialysis as a clinical monitoring technique assisting in the management of patients on an intention to treat basis. This involves establishing the relationship between microdialysis and outcome, and the effect of therapeutic manoeuvres on the chemistry. This manuscript describes the place of microdialysis in traumatic brain injury in terms of the fundamental principles, methodology, pathophysiology and clinical application.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16463898     DOI: 10.1007/3-211-32318-x_91

Source DB:  PubMed          Journal:  Acta Neurochir Suppl        ISSN: 0065-1419


  10 in total

1.  The impact of bevacizumab on temozolomide concentrations in intracranial U87 gliomas.

Authors:  Rachel Grossman; Michelle A Rudek; Harry Brastianos; Patti Zadnik; Henry Brem; Betty Tyler; Jaishri O Blakeley
Journal:  Cancer Chemother Pharmacol       Date:  2012-05-27       Impact factor: 3.333

Review 2.  Long-Term Consequences of Traumatic Brain Injury: Current Status of Potential Mechanisms of Injury and Neurological Outcomes.

Authors:  Helen M Bramlett; W Dalton Dietrich
Journal:  J Neurotrauma       Date:  2014-12-19       Impact factor: 5.269

3.  Incretin Mimetics as Rational Candidates for the Treatment of Traumatic Brain Injury.

Authors:  Elliot J Glotfelty; Thomas Delgado; Luis B Tovar-Y-Romo; Yu Luo; Barry Hoffer; Lars Olson; Tobias Karlsson; Mark P Mattson; Brandon Harvey; David Tweedie; Yazhou Li; Nigel H Greig
Journal:  ACS Pharmacol Transl Sci       Date:  2019-02-11

4.  Cyclosporin A preserves mitochondrial function after traumatic brain injury in the immature rat and piglet.

Authors:  Todd J Kilbaugh; Sunita Bhandare; David H Lorom; Manda Saraswati; Courtney L Robertson; Susan S Margulies
Journal:  J Neurotrauma       Date:  2011-04-12       Impact factor: 5.269

Review 5.  Monitoring Neurochemistry in Traumatic Brain Injury Patients Using Microdialysis Integrated with Biosensors: A Review.

Authors:  Chisomo Zimphango; Farah C Alimagham; Keri L H Carpenter; Peter J Hutchinson; Tanya Hutter
Journal:  Metabolites       Date:  2022-04-26

Review 6.  Microdialysis: is it ready for prime time?

Authors:  J Clay Goodman; Claudia S Robertson
Journal:  Curr Opin Crit Care       Date:  2009-04       Impact factor: 3.687

7.  The neurological wake-up test does not alter cerebral energy metabolism and oxygenation in patients with severe traumatic brain injury.

Authors:  Karin Skoglund; Lars Hillered; Karlis Purins; Parmenion P Tsitsopoulos; Johanna Flygt; Henrik Engquist; Anders Lewén; Per Enblad; Niklas Marklund
Journal:  Neurocrit Care       Date:  2014-06       Impact factor: 3.210

Review 8.  Bench-to-Bedside and Bedside Back to the Bench; Seeking a Better Understanding of the Acute Pathophysiological Process in Severe Traumatic Brain Injury.

Authors:  Denes V Agoston
Journal:  Front Neurol       Date:  2015-03-17       Impact factor: 4.003

Review 9.  The Importance of Therapeutic Time Window in the Treatment of Traumatic Brain Injury.

Authors:  Maliheh Mohamadpour; Kristen Whitney; Peter J Bergold
Journal:  Front Neurosci       Date:  2019-01-23       Impact factor: 4.677

Review 10.  Glucose and the injured brain-monitored in the neurointensive care unit.

Authors:  Elham Rostami
Journal:  Front Neurol       Date:  2014-06-06       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.